Naples Prognostic Score: A Novel Prognostic Score in Predicting Cancer-Specific Survival in Patients With Resected Esophageal Squamous Cell Carcinoma

被引:33
|
作者
Feng, Ji-Feng [1 ]
Zhao, Jian-Ming [2 ]
Chen, Sheng [1 ]
Chen, Qi-Xun [1 ]
机构
[1] Univ Chinese Acad Sci, Chinese Acad Sci,Dept Thorac Oncol Surg, Key Lab Diag & Treatment Technol Thorac Oncol,Can, Inst Canc Res & Basic Med Sci,Zhejiang Canc Hosp, Hangzhou, Peoples R China
[2] Jinhua Guangfu Hosp, Dept Thorac Surg, Jinhua, Peoples R China
来源
FRONTIERS IN ONCOLOGY | 2021年 / 11卷
关键词
Naples prognostic score; esophageal squamous cell carcinoma; neutrophil to lymphocyte ratio; lymphocyte to monocyte ratio; cancer-specific survival; prognosis; STATISTICS; SURGERY;
D O I
10.3389/fonc.2021.652537
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background Naples prognostic score (NPS) serves as a new prognostic index based on nutritional and inflammatory status in recent years. The aim of the current study was to explore the prognostic effect of NPS and to develop and validate a reliable nomogram based on NPS for individual cancer-specific survival (CSS) prediction in patients with resected ESCC without neoadjuvant therapy. Methods The clinical data for 287 (Jan. 2010 to Jun. 2012, Training sets) and 118 (Jan. 2015 to Dec 2015, Validation sets) consecutive resected ESCC cases were retrospectively analyzed. Two NPS models based on the different cut-off values of parameters were compared. Cut-off values in model 1 were derived from previous published studies, while cut-off values in model 2 were obtained in this study based on receiver operating characteristic (ROC) curves. The relationships between NPS and clinical characteristics and CSS were analyzed. The prediction model of nomogram was developed with independent prognostic factors in the training sets and was validated in the validation sets. Results The 5-year CSS for NPS 0, 1 and 2 were 61.9%, 34.6% and 13.4% in model 1 and 75.0%, 42.4% and 13.0% in model 2, respectively (P<0.001). Subgroup analyses revealed that NPS was also significantly associated with CSS in both model 1 and model 2 in different TNM stages. Multivariate analyses revealed that NPS was an independent prognostic marker regarding CSS in patients with resected ESCC (P<0.001). A predictive nomogram based on NPS was established and validated. The C-indexes of the nomogram in the training sets and validation sets were 0.68 and 0.72 in model 1 and 0.69 and 0.73 in model 2, respectively. These results confirmed that NPS-based nomogram was a more accurate and effective tool for predicting CSS in patients with resected ESCC. Conclusion The current study confirmed that NPS was still a useful independent prognostic score in patients with resected ESCC. The NPS-based nomogram was successfully developed and validated, which may contribute to individual CSS prediction for resected ESCC patients.
引用
收藏
页数:15
相关论文
共 50 条
  • [21] Predictive role of Naples prognostic score for survival in esophageal cancer: A meta-analysis
    Guo, Hongmei
    Wang, Ting
    MEDICINE, 2024, 103 (21) : E38160
  • [22] Prognostic Model for Predicting Overall and Cancer-Specific Survival Among Patients With Cervical Squamous Cell Carcinoma: A SEER Based Study
    Li, Zhuolin
    Lin, Yao
    Cheng, Bizhen
    Zhang, Qiaoxin
    Cai, Yingmu
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [23] Naples Prognostic Score: A Novel Predictor of Survival in Patients with Triple-Negative Breast Cancer
    Qiu, Yu
    Chen, Yan
    Shen, Haoyang
    Yan, Shuixin
    Li, Jiadi
    Wu, Weizhu
    JOURNAL OF INFLAMMATION RESEARCH, 2024, 17 : 5253 - 5269
  • [24] The prognostic value of modified Glasgow prognostic score in patients with esophageal squamous cell cancer: a Meta-analysis
    Wang, Yan
    Chen, Lu
    Wu, Yanming
    Li, Pengfei
    Che, Guowei
    NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL, 2020, 72 (07): : 1146 - 1154
  • [25] The Naples prognostic score in esophagus cancer: Prognostic and beyond
    Demir, Metin
    Demircan, Nazim Can
    BULLETIN DU CANCER, 2023, 110 (10) : 1027 - 1040
  • [26] Validation of the CAIX score as a prognostic biomarker for lymphatic spread and cancer-specific survival
    Chamie, Karim
    Said, Jonathan W.
    Belldegrun, Arie S.
    Pantuck, Allan J.
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (04)
  • [27] Gustave Roussy Immune Score (GRIm-Score) is a prognostic marker in patients with resectable esophageal squamous cell carcinoma
    Feng, Ji-Feng
    Wang, Liang
    Yang, Xun
    Chen, Sheng
    JOURNAL OF CANCER, 2020, 11 (06): : 1334 - 1340
  • [28] VALIDATION OF THE CAIX SCORE AS A PROGNOSTIC BIOMARKER FOR LYMPHATIC SPREAD AND CANCER-SPECIFIC SURVIVAL
    Chamie, Karim
    Said, Jonathan
    Belldegrun, Arie S.
    Pantuck, Allan J.
    JOURNAL OF UROLOGY, 2014, 191 (04): : E383 - E383
  • [29] Prognostic Significance of the Lung Immune Prognostic Index in Patients with Resected Esophageal Squamous Cell Carcinoma
    Feng, Ji-Feng
    Zhao, Jian-Ming
    Chen, Sheng
    Chen, Qi-Xun
    CANCER MANAGEMENT AND RESEARCH, 2021, 13 : 2811 - 2819
  • [30] Prognostic impact of controlling nutritional status score in resected lung squamous cell carcinoma
    Toyokawa, Gouji
    Kozuma, Yuka
    Matsubara, Taichi
    Haratake, Naoki
    Takamori, Shinkichi
    Akamine, Takaki
    Takada, Kazuki
    Katsura, Masakazu
    Shimokawa, Mototsugu
    Shoji, Fumihiro
    Okamoto, Tatsuro
    Maehara, Yoshihiko
    JOURNAL OF THORACIC DISEASE, 2017, 9 (09) : 2942 - +